Available technologies2018-09-25T17:57:47+00:00

Available technologies

On-Belt Tomosynthesis – A Low Cost 3D Imaging System

Professor Robert Speller and his team at University College London have developed a novel On-Belt Tomosynthesis system with the potential to produce high quality 3D composite images, at low cost, whilst baggage remains in transit through an airport conveyor system. This technology is currently available for licensing and UCL Business PLC, UCL wholly owned commercialisation company, are actively seeking partners for onward development.
More info →

Dry Eye Diagnosis and Monitoring Software

Clinicians at Moorfields Eye Hospital, the leading provider of eye health services in Europe have developed the first medical device which is able to quantify dry eye in a patient. The software quantifies the number, distribution and size of fluorescein staining allowing screening, diagnosis and monitoring of the dry eye and other eye diseases.
More info →

Delivery Device for Percutaneous Heart Valve

Delivery and recapture system and method for transcatheter prosthetic devices.
More info →

Voltage-Gated Sodium Channel Knockout Mice: Tools for Developing Therapeutics for the Treatment of Pain

Scientists at University College London have developed Voltage-Gated Sodium Channel subtype specific conditional knockout mice which provide invaluable tools for the development of therapeutics for the treatment of pain.
More info →

Dengue Virus High-Throughput Fluorescent Assay

We have developed a novel fluorescent assay for the screening of small molecules targeting dengue virus.
More info →

H4R antagonists for uveitis and other inflammatory diseases

Histamine is a pleiotropic mediator involved in a variety of physiological processes including neurotransmission, endocrine and vascular processes. It also plays a key role in inflammation and binding to one of its four receptors (H1R-H4R). Researchers at UCL Institute of Ophthalmology have shown that targeting H4R receptor in the central nervous system can be beneficial for patients with intraocular retinal inflammatory disease including non-infectious uveitis.
More info →


OpSAFE is a medical device that enables touch free use of OsiriX MD image viewer for medical images.
More info →

New lentiviral platform eliminating packaging sequences from the transcribed DNA region

All lentiviral vectors described to date contain packaging sequences necessary for the viral RNA genome to be assembled into viral particles. These sequences are unnecessarily reverse transcribed into DNA and permanently integrate into target cells. The researchers at UCL Institute of Child Health have developed a lentiviral platform which does not reverse transcribe the packaging sequences into the target cells.
More info →

Compliment Factor H Related 5 protein (CFHR5) and kidney disease

We have demonstrated that an abnormality of the protein Complement Factor H Related 5 (CFHR5) leads to a disposition of complement C3 and kidney failure. we have invented an efficient test for this genetic abnormality and have used it to screen a population. We have also invented an ELISA assay to measure the circulating CFHR5 protein levels in humans. We believe this will be useful in diagnosis and assessment of patients with a variety of diseases including SLE, immune complex glomerulonephritis and perhaps age-related macular degeneration. We have also proposed a role for CFHR5 protein (or agents mimicking its action) in the treatment of these diseases and are currently testing this experimentally.
More info →